Ribosome-binding protein 1
Ribosome-binding protein 1 (879-887) is a synthetic peptide fragment derived from the C-terminal region of the ribosome-binding protein 1 (RRBP1), a key component associated with the rough endoplasmic reticulum and involved in ribosome docking and protein translocation. This peptide encompasses amino acid residues 879 to 887, representing a defined epitope within the larger RRBP1 sequence. Its biochemical significance lies in its role as a molecular tool for probing protein-protein interactions, post-translational modifications, and subcellular localization mechanisms relevant to the protein synthesis machinery. Researchers utilize such sequence-defined peptides to dissect the functional domains of RRBP1, investigate cellular trafficking pathways, and explore the regulatory networks governing translation and endoplasmic reticulum dynamics.
Epitope mapping: As a well-defined peptide corresponding to a specific region of RRBP1, the 879-887 fragment is frequently employed in epitope mapping studies. By serving as a target for antibody production or screening, it enables researchers to identify and validate antibody binding sites within the RRBP1 protein. This application is particularly valuable in the development and characterization of monoclonal or polyclonal antibodies, supporting downstream applications such as immunoprecipitation, immunoblotting, or immunofluorescence assays.
Protein-protein interaction studies: The peptide serves as a model substrate for investigating the molecular interactions between RRBP1 and its binding partners. By immobilizing or labeling this fragment, researchers can perform pulldown assays, surface plasmon resonance experiments, or other biophysical analyses to delineate the binding affinities and specificities of interacting proteins. Such studies provide insight into the mechanistic aspects of ribosome docking, translocon assembly, and the orchestration of protein synthesis at the endoplasmic reticulum.
Phosphorylation and post-translational modification analysis: The 879-887 sequence of RRBP1 may encompass potential sites for phosphorylation or other post-translational modifications. Synthetic peptides corresponding to this region are instrumental in kinase assays, mass spectrometry-based mapping, or in vitro modification studies. By enabling the precise identification and functional characterization of modification sites, the peptide contributes to a deeper understanding of the regulatory mechanisms that modulate RRBP1 activity and its cellular roles.
Peptide-based assay development: The defined sequence of the 879-887 fragment allows for its incorporation into custom assay platforms, including enzyme-linked immunosorbent assays (ELISAs), competitive binding assays, and biosensor applications. These assays facilitate the quantitative detection of antibodies, enzymes, or interacting proteins with high specificity, supporting high-throughput screening and analytical workflows in both academic and industrial research settings.
Structural and functional domain analysis: As an isolated segment of RRBP1, the peptide is a valuable tool for dissecting the structural determinants of the parent protein. Researchers can utilize it in conformational studies, such as circular dichroism or nuclear magnetic resonance spectroscopy, to assess secondary structure propensity and domain organization. These investigations contribute to the broader understanding of how discrete sequence motifs within RRBP1 contribute to its functional architecture and biological activity within the cellular context.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.